About Gilead Sciences
Gilead Sciences is a US research-based biopharmaceutical company that focuses on the development and commercialisation of medicines for life-threatening illnesses. It was founded in 1987 and has headquarters in California. In particular, the company’s antiviral drugs are used in the treatment of influenza, HIV/AIDS, Hepatitis B and C, and liver, cardiovascular and respiratory diseases. Gilead Sciences provides access to medicines to more than 12 million people across 140 countries worldwide. It has also participated in joint ventures with other pharmaceutical giants such as Merck, Bristol-Myers Squibb and Verily. Gilead Sciences stock is listed on the Nasdaq exchange and is a constituent of the Nasdaq-100 and S&P 500 indices. Start spread betting or trading CFDs on our Gilead Sciences share price.
Why trade Gilead Sciences with CMC Markets?
We've invested over £100m into our trading platform, creating pioneering technology that puts professional-grade grade software in your hands.
Set your default position size and enter with a single 'click'.
99.9% fill rate with 0.0029s execution*
Wherever possible we fill your trade and always at the price you see.
99.95%+ platform stability**
We consistently achieve core platform uptime, allowing you to focus on your trading.
We crunch 225m prices every day, from up to 14 feeds from tier one liquidity providers.